Top-News
Schweden

MEDIVIR AB News

Aktie
WKN:  A3EFZT ISIN:  SE0020181014 US-Symbol:  MVRBF
0,248 €
+0,00 €
0,00%
26.07.24
Handeln Depot/Watchlist
Aktienanzahl *
55,74 Mio.
Marktkapitalisierung *
12,21 Mio. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 22.05.2023

MEDIVIR AB News

19.08.22 - PLX
Medivir Q2 Revenue SEK 500 Thousand vs. Estimate SEK 500 Thousand
(PLX AI) – Medivir Q2 adjusted EBITDA SEK -21.5 million. • Q2 adjusted free cash flow SEK -17.6 million
19.08.22 - PR Newswire
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022
MEDIVIR AB - INTERIM REPORT JANUARY - JUNE 2022 PR Newswire
15.02.22 - PLX
Medivir Q4 EPS SEK -0.44
(PLX AI) – Medivir Q4 revenue SEK 13.9 million.
04.11.21 - PR Newswire
Birinapant clinical study initiated by IGM Biosciences
Birinapant clinical study initiated by IGM Biosciences PR Newswire
03.11.21 - PLX
Medivir Q3 EPS SEK -0.26
(PLX AI) – Medivir Q3 revenue SEK 800 thousand.
25.10.21 - PLX
Medivir Names Jens Lindberg New CEO
(PLX AI) – Medivir appoints Jens Lindberg as Chief Executive Officer. • He joins from Sedana Medical where he has been VP Commercial and acting CEO • Will assume position within ...
11.10.21 - PR Newswire
Medivir to present at the ProHearings shared Capital Markets Day
Medivir to present at the ProHearings shared Capital Markets Day PR Newswire
16.09.21 - PLX
Medivir Says MIV-818 Phase 1b Study Had Positive Results
(PLX AI) – Medivir positive study results of MIV-818 in HCC dose escalation section of the phase 1b study. • The overall safety profile was in line with expectations for this type of drug ...
19.08.21 - PLX
Medivir Q2 EPS SEK -0.35
(PLX AI) – Medivir Q2 revenue SEK 900 thousand.
01.07.21 - PR Newswire
Medivir appoints Malene Jensen as VP Clinical Development
Medivir appoints Malene Jensen as VP Clinical Development PR Newswire
01.06.21 - PR Newswire
Medivir to present at the Redeye Growth Day
Medivir to present at the Redeye Growth Day PR Newswire
25.05.21 - PR Newswire
Medivir to present at the ABGSC Life Science Summit
Medivir to present at the ABGSC Life Science Summit PR Newswire
25.05.21 - PR Newswire
Medivir announces the design of its upcoming MIV-818 combination study
Medivir announces the design of its upcoming MIV-818 combination study PR Newswire
20.05.21 - PR Newswire
Positive results from investigator-initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published
Positive results from investigator-​initiated phase II clinical study of remetinostat in patients with squamous cell carcinoma published PR Newswire
05.05.21 - PR Newswire
Resolutions at the Annual General Meeting in Medivir on 5 May 2021
Resolutions at the Annual General Meeting in Medivir on 5 May 2021 PR Newswire
28.04.21 - PR Newswire
Medivir AB - Interim Report January - March 2021
Medivir AB - Interim Report January - March 2021 PR Newswire
20.04.21 - PR Newswire
Medivir to participate at the Kempen Life Sciences Conference
Medivir to participate at the Kempen Life Sciences Conference PR Newswire
19.04.21 - PR Newswire
Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818
Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818 PR Newswire
06.04.21 - PR Newswire
Medivir 2020 Annual Report published
Medivir 2020 Annual Report published PR Newswire
31.03.21 - PR Newswire
Number of shares and votes in Medivir
Number of shares and votes in Medivir PR Newswire

Newssuche

Videos

newspaper
25.07.24 -7,23%
Technical Trading: DAX Short Chance
DAX Short Typ: Turbo Open End WKN: PG4LWT Hebel: 8,5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »